Inogen Inc (INGN) is a publicly traded Healthcare sector company. As of May 21, 2026, INGN trades at $6.07 with a market cap of $170.57M and a P/E ratio of -6.88. INGN moved -1.71% today. Year to date, INGN is -4.66%; over the trailing twelve months it is +1.12%. Its 52-week range spans $5.34 to $12.91. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces INGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Inogen Narrows Q4 Loss to $0.15 EPS on 2% Revenue Growth, International Sales Up 14.8%: Inogen reported a fourth-quarter adjusted loss of $0.15 per share, narrower than the year-ago $0.24 loss and consensus $0.36 loss, on revenues of $81.7 million, up 2% y/y but 0.3% below estimates. International sales climbed 14.8% to $32.5 million, while U.S. sales dipped 5.1% and rental revenue fell 4.5%.
| Metric | Value |
|---|---|
| Price | $6.07 |
| Market Cap | $170.57M |
| P/E Ratio | -6.88 |
| EPS | $-0.92 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.91 |
| 52-Week Low | $5.34 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $351.50M |
| Net Income | $-24.90M |
| Gross Margin | 44.31% |
2 analysts cover INGN: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.